JPRN-jRCT2051210017进行中（未招募）3 期
An extension study for seven patients in Japan with neuromyelitis optica spectrum disorder who completed the open-label period of study CD-IA-MEDI-551-1155 of Inebilizumab
Sato Toshiyuki0 个研究点目标入组 7 人开始时间: 2021年5月7日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Has completed at least 2 years in the OLP of Study CD-IA-MEDI-551-1155, and has not discontinued inebilizumab treatment in that study
- •Is deemed eligible to continue receiving inebilizumab by the Investigator
排除标准
- •Has any condition that, in the opinion of the Investigator, would place the patient at unacceptable risk of complications, interfere with evaluation of inebilizumab or confound the interpretation of patient safety or study results
- •Lactating or pregnant females, or females who intend to become pregnant after signing the informed consent
研究者
相似试验
尚未招募
不适用
Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19inflammatory bowel disease COVID-19JPRN-UMIN000040656Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine200
已完成
不适用
Japan Prospective Long Term Clinical Trial in Type 2 Diabetes Patients with Sulfonyl Urea and SitagliptiType 2 diabetesJPRN-UMIN000005415Kyoto University Graduate School of Medicine250
招募中
不适用
Exploratory Clinical Trial of EPI-743 in Japanese MELAS Syndrome PatientsMELAS: mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodesJPRN-UMIN000010783ational Center of Neurology and Psychiatry, Japan10
已完成
2 期
Japanese phase II study in untreated patients with CD20 positive B-cell non-Hodgkin's lymphoma evaluating safety of 90-minute infusion of rituximab.CD20 positive follicular lymphoma or diffuse large B-cell lymphoma.JPRN-jRCT2080223607ZENYAKU KOGYO CO., LTD.33
已完成
不适用
Observation study for Japanese patients with head and neck cancer by combination therapy with cetuximabsquamous-cell carcinoma of head and neckJPRN-UMIN000011911Japanese Oncology Radiation Study Group300